ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 87 filers reported holding ALLOVIR INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $48,638 | +11.0% | 64,430 | 0.0% | 0.00% | – |
Q4 2023 | $43,800 | -71.2% | 64,430 | -8.8% | 0.00% | – |
Q3 2023 | $151,941 | -25.9% | 70,670 | +17.2% | 0.00% | – |
Q2 2023 | $205,054 | +17.0% | 60,310 | +35.5% | 0.00% | – |
Q1 2023 | $175,330 | -12.4% | 44,500 | +14.1% | 0.00% | – |
Q4 2022 | $200,070 | -11.1% | 39,000 | +36.8% | 0.00% | – |
Q3 2022 | $225,000 | +114.3% | 28,500 | +6.3% | 0.00% | – |
Q2 2022 | $105,000 | -30.5% | 26,800 | +20.2% | 0.00% | – |
Q1 2022 | $151,000 | -47.8% | 22,300 | 0.0% | 0.00% | – |
Q4 2021 | $289,000 | -79.6% | 22,300 | -60.5% | 0.00% | -100.0% |
Q3 2021 | $1,414,000 | -94.6% | 56,440 | -95.8% | 0.00% | -90.9% |
Q2 2021 | $26,336,000 | +2.3% | 1,334,129 | +21.3% | 0.01% | 0.0% |
Q1 2021 | $25,735,000 | -34.5% | 1,099,800 | +7.7% | 0.01% | -42.1% |
Q4 2020 | $39,271,000 | +49.0% | 1,021,611 | +6.6% | 0.02% | +35.7% |
Q3 2020 | $26,365,000 | – | 958,743 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 2,323,371 | $63,893,000 | 1.55% |
Redmile Group, LLC | 2,333,390 | $64,168,000 | 1.18% |
Woodline Partners LP | 1,191,014 | $32,753,000 | 1.07% |
EcoR1 Capital, LLC | 447,012 | $12,293,000 | 0.88% |
Samsara BioCapital, LLC | 91,057 | $2,504,000 | 0.70% |
SECTORAL ASSET MANAGEMENT INC | 277,795 | $7,639,000 | 0.66% |
CNA FINANCIAL CORP | 10,745 | $295,000 | 0.11% |
Marshall Wace North America L.P. | 580,880 | $15,974,000 | 0.10% |
MIRABELLA FINANCIAL SERVICES LLP | 16,791 | $462,000 | 0.06% |
Alkeon Capital Management | 1,097,000 | $30,167,000 | 0.06% |